Center hosts inaugural conference joined by leaders from across public and private sectors
The World Health Organization’s governing body is scheduled to meet on May 27 to discuss a critically needed plan for global pandemic preparedness.
What’s the best way to communicate with a vaccine-hesitant person about a vaccine’s potential benefits? New research from Binghamton University, State University of New York found that a one-size-fits-all approach to communicating messages isn’t effective.
A study by researchers at Washington University School of Medicine in St. Louis has found that repeat vaccination with updated versions of the COVID-19 vaccine promotes the development of antibodies that neutralize a wide range of variants of the virus that causes COVID-19, as well as related coronaviruses.
Vaccines remain the gold standard of protection against dangerous pathogens, but take considerable time and vast resources to develop. Rapidly mutating viruses such as SARS-CoV-2 can blunt their effectiveness and even render them obsolete.
Researchers have developed a groundbreaking electrostatic air sampler that enhances the rapid monitoring of airborne influenza and coronavirus. The device, capable of high air flow rates, offers significant advancements in detecting viral presence in indoor environments through polymerase chain reaction (PCR) analysis.
Leptospirosis is an illness caused by a bacteria called leptospira that can be present in soil and stagnant water. Rodents and other wildlife carry the bacteria and spread it through their urine. Both humans and dogs can become sick with leptospirosis, while cats are considered disease-resistant. For both people and dogs, the result of infection can range from mild to deadly serious.
Changing people’s behavior until a vaccine could be developed prevented roughly 800,000 COVID-19 deaths in the U.S., according to new CU Boulder and UCLA research. But the authors stress that interventions like lockdowns and school closures came at great economic and social cost.
Researchers at Fred Hutch Cancer Center have found in pre-clinical studies that an experimental gene therapy for genital and oral herpes removed 90% or more of the infection and suppressed how much virus can be released from an infected individual, which suggests that the therapy would also reduce the spread of the virus.
Researchers from the Biological Threat Response Laboratory played a critical role in testing for the virus.
Member States of the World Health Organization (WHO) were due to converge on text for a global pandemic agreement during their ninth and final negotiating session in March; however, insufficient progress was made in those two weeks, in terms of finding consensus.
Over 150 researchers from across the University of Utah gathered to form new connections and share groundbreaking research on topics from antibiotic resistance to autoimmune diseases.
A group of UC San Diego researchers, centered at UC San Diego's Institute for Network Medicine, teamed up with rheumatologists at the University of Leeds in the United Kingdom to solve a medical mystery.
Shruti Mehta, PhD, MPH, has been named The Dr. Charles Armstrong Chair in Epidemiology and Professor in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health, effective June 1.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right